Drug
[15-O]water
[15-O]water is a pharmaceutical drug with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
1
25%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
Phase 2Efficacy & side effects
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (50.0%)
Phase 21 (50.0%)
Trials by Status
completed375%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
completed
Protein Synthesis in the Brain of Patients With Fragile X Syndrome
NCT00362843
terminatedphase_1
Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
NCT01246869
completed
Sex and Obesity: Effects on Heart Failure Study
NCT00776035
completedphase_2
Renal Blood Flow Measurement With Positron Emission Tomography (PET)
NCT00714142
Clinical Trials (4)
Showing 4 of 4 trials
NCT00362843
Protein Synthesis in the Brain of Patients With Fragile X Syndrome
NCT01246869Phase 1
Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
NCT00776035
Sex and Obesity: Effects on Heart Failure Study
NCT00714142Phase 2
Renal Blood Flow Measurement With Positron Emission Tomography (PET)
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4